EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Impact of intensive versus nonintensive antithrombotic treatment on device-related thrombus after left atrial appendage closure

Philippe Garot, Pedro Cepas-Guillén, Eduardo Flores-Umanzor, Nina Leduc, Vilhemas Bajoras, Nils Perrin, Angela McInerney, Ana Lafond, Julio Farjat-Pasos, Xavi Millán, Sandra Zendjebil, Reda Ibrahim und 11 weitere

Revista Española de Cardiología (English Edition) · 2025

DOI: 10.1016/j.rec.2024.11.006 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2025. Verfasst von Philippe Garot und 22 weiteren Autor:innen. Beteiligte Einrichtung: Institut Cardiovasculaire Paris-Sud (ICPS), Hôpital Jacques Cartier, Ramsay-Santé, Massy, France. Electronic address: p.garot@angio-icps.com. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Cardiac Surgical Procedures, Fibrinolytic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: The optimal antithrombotic therapy (AT) after left atrial appendage closure (LAAC) is debated. We assessed the impact of intensive vs nonintensive AT on the incidence of device-related thrombus (DRT) based on whether the device implantation was classified as optimal or suboptimal. METHODS: This study included patients who underwent successful LAAC in 9 centers. Patients were classified according to the quality of device implantation: optimal (proximal implant without ≥3mm peridevice leak) or suboptimal (distal implant and/or ≥3mm peridevice leak). Postimplant AT was classified as either intensive (dual antiplatelet therapy, anticoagulants, or a combination of both) or nonintensive (no AT or a single antiplatelet therapy). The primary endpoint was the incidence of DRT between the 6th and 12th weeks postprocedure. RESULTS: A total of 1225 patients underwent LAAC, with 757 (61.8%) achieving optimal device implantation and 468 (38.2%) classified as suboptimal. After a median follow-up of 20 months, the incidence of DRT in the optimal implant group was 2.6% with intensive AT and 3.7% with nonintensive AT (P=.38). In the suboptimal implant group, the incidence of DRT increased to 11.2% with intensive AT and 15.5% with nonintensive AT (P=.19). On multivariate analysis, suboptimal implantation (HR, 4.51; 95%CI, 2.70-7.54, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationCardiac Surgical ProceduresFibrinolytic AgentsPostoperative ComplicationsSeptal Occluder DeviceThrombosisAgedFemaleHumansMaleFollow-Up StudiesIncidenceLeft Atrial Appendage ClosureRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

Antiagregación plaquetariaAnticoagulaciónAnticoagulantsAntiplatelet agentsAtrial fibrillationCierre de la orejuela izquierdaDevice-related thrombosisFibrilación auricularIctusLeft atrial appendage closureStrokeTrombosis relacionada con el dispositivo

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • Institut Cardiovasculaire Paris-Sud (ICPS), Hôpital Jacques Cartier, Ramsay-Santé, Massy, France. Electronic address: p.garot@angio-icps.com.
  • Institut Clínic Cardiovascular (ICCV), Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Interventional Cardiology, Institut Universitair…
  • Institut Clínic Cardiovascular (ICCV), Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Department of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium.
  • Department of Cardiology, Rigshospitalet, Copenhagen, Denmark; Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Department of Interven…
  • Department of Interventional Cardiology, Montreal Heart Institute, Universite de Montreal, Montreal, Canada.

Zitieren

APA

Garot, P., Cepas-Guillén, P., Flores-Umanzor, E., Leduc, N., Bajoras, V., Perrin, N., McInerney, A., Lafond, A., Farjat-Pasos, J., Millán, X., Zendjebil, S., Ibrahim, R., Salinas, P., de Backer, O., Cruz-González, I., Arzamendi, D., Sanchis, L., Nombela-Franco, L., ÓHara, G., …, & Freixa, X. (2025). Impact of intensive versus nonintensive antithrombotic treatment on device-related thrombus after left atrial appendage closure. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2024.11.006

Vancouver

Garot P, Cepas-Guillén P, Flores-Umanzor E, Leduc N, Bajoras V, Perrin N, et al. Impact of intensive versus nonintensive antithrombotic treatment on device-related thrombus after left atrial appendage closure. Revista Española de Cardiología (English Edition). 2025. doi:10.1016/j.rec.2024.11.006

BibTeX
@article{Garot2025,
  author = {Garot, Philippe and Cepas-Guillén, Pedro and Flores-Umanzor, Eduardo and Leduc, Nina and Bajoras, Vilhemas and Perrin, Nils and McInerney, Angela and Lafond, Ana and Farjat-Pasos, Julio and Millán, Xavi and Zendjebil, Sandra and Ibrahim, Reda and Salinas, Pablo and de Backer, Ole and Cruz-González, Ignacio and Arzamendi, Dabit and Sanchis, Laura and Nombela-Franco, Luis and ÓHara, Gilles and Aminian, Adel and Nielsen-Kudsk, Jens Erik and Rodés-Cabau, Josep and Freixa, Xavier},
  title = {Impact of intensive versus nonintensive antithrombotic treatment on device-related thrombus after left atrial appendage closure},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2025},
  doi = {10.1016/j.rec.2024.11.006}
}
Kostenlos starten →